Thomas Blackmore

Thomas Blackmore is a Research Scientist at COMPASS Pathways since October 2021, specializing in the development and validation of cognitive and behavioral assays in rodents, particularly in transgenic models of neurodegeneration. Prior experience includes a DPhil in Interdisciplinary Biosciences from the University of Oxford (2017-2021), a Research Assistant role at Eli Lilly and Company (2013-2017) focusing on progressive functional decline, and a Placement Student position at Boehringer Ingelheim (2011-2012) working on cognitive assays related to normal aging in murine models. Educational background includes a Bachelor's Degree in Pharmacology from The University of Manchester (2009-2013) and studies at Pate's Grammar School (2002-2009).